Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymorphism, Single Nucleotide | 25 | 2017 | 860 | 0.760 |
Why?
|
| Breast Feeding | 1 | 2023 | 123 | 0.730 |
Why?
|
| Genome-Wide Association Study | 11 | 2017 | 421 | 0.650 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2017 | 744 | 0.570 |
Why?
|
| Self Care | 1 | 2016 | 173 | 0.460 |
Why?
|
| Sleep Apnea, Obstructive | 5 | 2012 | 56 | 0.450 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 234 | 0.450 |
Why?
|
| Health Education | 1 | 2016 | 358 | 0.410 |
Why?
|
| Telemedicine | 1 | 2016 | 215 | 0.400 |
Why?
|
| Coronary Disease | 5 | 2014 | 123 | 0.370 |
Why?
|
| Genetic Loci | 6 | 2015 | 102 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2016 | 727 | 0.340 |
Why?
|
| Genotype | 16 | 2017 | 796 | 0.330 |
Why?
|
| Genome, Human | 6 | 2012 | 143 | 0.300 |
Why?
|
| Electrocardiography | 4 | 2016 | 184 | 0.290 |
Why?
|
| Triglycerides | 4 | 2012 | 146 | 0.290 |
Why?
|
| Cholesterol, HDL | 6 | 2014 | 99 | 0.270 |
Why?
|
| Female | 30 | 2023 | 24018 | 0.240 |
Why?
|
| Humans | 39 | 2023 | 42163 | 0.220 |
Why?
|
| Florida | 2 | 2023 | 461 | 0.220 |
Why?
|
| Chromosome Mapping | 6 | 2011 | 198 | 0.220 |
Why?
|
| Stroke | 3 | 2014 | 348 | 0.220 |
Why?
|
| Lipoproteins, HDL | 2 | 2015 | 48 | 0.210 |
Why?
|
| Middle Aged | 22 | 2017 | 11819 | 0.200 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2023 | 35 | 0.200 |
Why?
|
| Adiponectin | 2 | 2013 | 59 | 0.190 |
Why?
|
| Body Mass Index | 7 | 2015 | 916 | 0.190 |
Why?
|
| Phenotype | 11 | 2015 | 774 | 0.180 |
Why?
|
| Insulin Resistance | 3 | 2013 | 199 | 0.180 |
Why?
|
| Male | 29 | 2017 | 22779 | 0.170 |
Why?
|
| Cholesterol, LDL | 4 | 2014 | 73 | 0.170 |
Why?
|
| Mothers | 1 | 2023 | 212 | 0.170 |
Why?
|
| Obesity | 4 | 2015 | 1131 | 0.170 |
Why?
|
| Infant, Newborn | 1 | 2023 | 960 | 0.160 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2014 | 11 | 0.160 |
Why?
|
| Lipids | 2 | 2012 | 256 | 0.160 |
Why?
|
| Infant | 1 | 2023 | 1143 | 0.160 |
Why?
|
| Linkage Disequilibrium | 4 | 2011 | 85 | 0.150 |
Why?
|
| Aged | 17 | 2014 | 7982 | 0.150 |
Why?
|
| Alcohol Drinking | 2 | 2014 | 585 | 0.150 |
Why?
|
| Alleles | 7 | 2016 | 352 | 0.140 |
Why?
|
| Genetic Variation | 4 | 2013 | 429 | 0.140 |
Why?
|
| Genetic Association Studies | 5 | 2014 | 118 | 0.120 |
Why?
|
| BRCA2 Protein | 1 | 2016 | 50 | 0.120 |
Why?
|
| Heart Ventricles | 1 | 2016 | 123 | 0.120 |
Why?
|
| Gallbladder Diseases | 1 | 2015 | 5 | 0.120 |
Why?
|
| Adult | 18 | 2015 | 13458 | 0.120 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 2006 | 9 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 83 | 0.110 |
Why?
|
| Child | 1 | 2023 | 3381 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 144 | 0.110 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2014 | 5 | 0.110 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2014 | 10 | 0.110 |
Why?
|
| Quantitative Trait Loci | 2 | 2012 | 88 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2016 | 733 | 0.110 |
Why?
|
| Sleep | 1 | 2015 | 179 | 0.100 |
Why?
|
| Rural Population | 1 | 2016 | 352 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 90 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 206 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2015 | 1729 | 0.100 |
Why?
|
| Lipid Metabolism | 2 | 2015 | 140 | 0.100 |
Why?
|
| Endothelin-1 | 1 | 2013 | 57 | 0.100 |
Why?
|
| Genealogy and Heraldry | 1 | 2012 | 5 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2014 | 662 | 0.100 |
Why?
|
| Body Weight | 1 | 2014 | 428 | 0.100 |
Why?
|
| Models, Genetic | 2 | 2004 | 181 | 0.100 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 66 | 0.100 |
Why?
|
| Gene Frequency | 5 | 2012 | 203 | 0.090 |
Why?
|
| Neoplasms | 1 | 2023 | 1341 | 0.090 |
Why?
|
| Risk Factors | 7 | 2015 | 3942 | 0.090 |
Why?
|
| Crossing Over, Genetic | 1 | 2011 | 6 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2011 | 3 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 10 | 0.090 |
Why?
|
| Cholesterol | 1 | 2012 | 230 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 234 | 0.090 |
Why?
|
| Sodium Channels | 1 | 2011 | 66 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 729 | 0.080 |
Why?
|
| Alcoholism | 1 | 2013 | 292 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 15 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 31 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2011 | 164 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2013 | 1266 | 0.070 |
Why?
|
| Leptin | 1 | 2009 | 118 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2008 | 68 | 0.070 |
Why?
|
| Polysomnography | 3 | 2015 | 41 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2014 | 2803 | 0.070 |
Why?
|
| Odds Ratio | 3 | 2014 | 587 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1068 | 0.060 |
Why?
|
| Pedigree | 4 | 2011 | 94 | 0.060 |
Why?
|
| Mississippi | 3 | 2010 | 129 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2004 | 7 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2004 | 10 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2004 | 11 | 0.050 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2004 | 19 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2010 | 641 | 0.050 |
Why?
|
| Smoking | 1 | 2011 | 1019 | 0.050 |
Why?
|
| Prevalence | 3 | 2017 | 1597 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 2 | 2014 | 34 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2003 | 27 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 297 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2014 | 1020 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 310 | 0.050 |
Why?
|
| Myocardium | 2 | 2016 | 251 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 236 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2014 | 386 | 0.040 |
Why?
|
| California | 1 | 2023 | 531 | 0.040 |
Why?
|
| Genetics, Population | 2 | 2011 | 118 | 0.040 |
Why?
|
| Lod Score | 3 | 2004 | 13 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1679 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2014 | 146 | 0.040 |
Why?
|
| Sex Factors | 3 | 2012 | 1008 | 0.040 |
Why?
|
| Age Factors | 1 | 2002 | 1139 | 0.040 |
Why?
|
| Gene Expression | 2 | 2012 | 692 | 0.040 |
Why?
|
| Prognosis | 2 | 2011 | 850 | 0.030 |
Why?
|
| Algorithms | 2 | 2011 | 508 | 0.030 |
Why?
|
| Minority Groups | 1 | 2023 | 663 | 0.030 |
Why?
|
| Haplotypes | 2 | 2011 | 197 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2017 | 92 | 0.030 |
Why?
|
| Young Adult | 3 | 2014 | 4936 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 454 | 0.030 |
Why?
|
| Adolescent | 3 | 2014 | 5950 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2016 | 74 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2015 | 68 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 83 | 0.030 |
Why?
|
| Microsatellite Repeats | 2 | 2004 | 60 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2014 | 90 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2004 | 8 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 56 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2014 | 75 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2014 | 190 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2006 | 574 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2013 | 65 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 165 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 358 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 289 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2012 | 34 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 602 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2013 | 238 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 76 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 487 | 0.020 |
Why?
|
| Insulin | 1 | 2014 | 255 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 71 | 0.020 |
Why?
|
| Africa, Western | 1 | 2011 | 19 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 428 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 30 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 94 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 114 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 82 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 87 | 0.020 |
Why?
|
| Systems Biology | 1 | 2011 | 26 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1848 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 42 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 33 | 0.020 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2010 | 5 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 81 | 0.020 |
Why?
|
| Georgia | 1 | 2010 | 189 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 114 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 366 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1054 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 261 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1574 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 299 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2011 | 180 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 997 | 0.020 |
Why?
|
| Software | 1 | 2011 | 234 | 0.020 |
Why?
|
| Genomics | 1 | 2011 | 289 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 382 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1559 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 324 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 311 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 638 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1001 | 0.020 |
Why?
|
| United States | 1 | 2017 | 5072 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 534 | 0.020 |
Why?
|
| Hypertension | 1 | 2013 | 823 | 0.020 |
Why?
|
| Heart Failure | 1 | 2009 | 298 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2004 | 14 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2004 | 30 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2004 | 27 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2004 | 37 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 56 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 123 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2002 | 7 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 200 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 2111 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 3077 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 1058 | 0.010 |
Why?
|